Safety and impact of the Mediterranean diet in patients with chronic kidney disease: a pilot randomized crossover trial.
Study Goal
The researchers aimed to assess the safety and short-term impact of the Mediterranean Proper Optimal Balance (MEDi-POB) diet on kidney function in Korean patients with stage 3-4 chronic kidney disease (CKD).
Results Summary
The MEDi-POB diet significantly increased dietary fat, fiber, and niacin intake while reducing sodium and copper intake. It also slightly improved metabolic acidosis management and maintained kidney function without adversely affecting serum or urine potassium levels.
Population
Korean patients with stage 3-4 CKD.
Effective Dosage
Home-delivered meals twice daily, 5 days a week.
Duration
4 weeks per intervention (with a 4-week washout period in between).
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
MEDi-POB diet | increase | Dietary fat intake | Korean patients with stage 3-4 CKD | p = 0.001 | significantly higher | #1 |
MEDi-POB diet | increase | fiber intake | Korean patients with stage 3-4 CKD | p < 0.001 | significantly higher | #2 |
MEDi-POB diet | increase | niacin intake | Korean patients with stage 3-4 CKD | p = 0.007 | significantly higher | #3 |
MEDi-POB diet | increase | total CO2 levels | Korean patients with stage 3-4 CKD | p = 0.043 | slightly increased | #4 |
MEDi-POB diet | decrease | sodium intake | Korean patients with stage 3-4 CKD | p = 0.032 | significantly lower | #5 |
MEDi-POB diet | decrease | copper intake | Korean patients with stage 3-4 CKD | p = 0.037 | significantly lower | #6 |
MEDi-POB diet | increase | Caloric intake | Korean patients with stage 3-4 CKD | - | increased | #7 |
MEDi-POB diet | decrease | body mass index | Korean patients with stage 3-4 CKD | - | slightly decreased | #8 |
MEDi-POB diet | no change | Dietary potassium intake | Korean patients with stage 3-4 CKD | p = 0.053 | non-significant increase | #9 |
MEDi-POB diet | no change | serum potassium levels | Korean patients with stage 3-4 CKD | p = 0.883 | no significant changes | #10 |
MEDi-POB diet | no change | urine potassium levels | Korean patients with stage 3-4 CKD | p = 0.087 | no significant changes | #11 |
MEDi-POB diet | no change | Kidney function | Korean patients with stage 3-4 CKD | - | remained well-preserved | #12 |
INTRODUCTION: Emerging evidence highlights the potential advantages of the Mediterranean diet (MD) in preserving kidney function and slowing chronic kidney disease (CKD) progression. However, interventional studies on the MD are scarce in East Asian populations. METHODS: This randomized crossover trial aimed to assess the safety and short-term impact of the Mediterranean Proper Optimal Balance (MEDi-POB) diet in Korean patients with stage 3-4 CKD. Kidney function was assessed using the estimated glomerular filtration rate, which was calculated using the CKD Epidemiology Collaboration equation. Fifty patients with CKD were randomly assigned to two groups, each starting with a different 4-week intervention, followed by a 4-week washout period, followed by a switch to the other 4-week intervention. During the MEDi-POB intervention, patients received home delivery of meals twice daily, 5 days a week, while the control intervention comprised a conventional diet. Forty-six patients successfully completed the entire 12-week trial. Paired t-tests were conducted to assess mean differences between the two groups. A linear mixed model was used to adjust for sequence and period. RESULTS: Dietary fat, fiber, and niacin intake were significantly higher following the MEDi-POB diet than following the control diet (p = 0.001 for fat, p < 0.001 for fiber, and p = 0.007 for niacin). The MEDi-POB diet also yielded slightly increased total CO2 levels (p = 0.043), indicating effective management of metabolic acidosis. Conversely, sodium and copper intake were significantly lower with the MEDi-POB diet (p = 0.032 and p = 0.037, respectively). Caloric intake increased, but body mass index slightly decreased from baseline after consuming the MEDi-POB diet. Dietary potassium intake exhibited a non-significant increase (p = 0.053), and no significant changes in serum (p = 0.883) and urine potassium levels (p = 0.087) occurred. Kidney function remained well-preserved following the MEDi-POB diet. CONCLUSION: These results indicate that the MEDi-POB diet is safe even in patients with advanced CKD, as it does not adversely affect serum and urine potassium levels and helps maintain kidney function.